CAS: 720690-73-3 - 6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide
Formula:C21H25N3O2
InChI:InChI=1S/C21H25N3O2/c1-22-21(25)17-6-8-20(23-14-17)26-19-7-5-15-9-11-24(18-3-2-4-18)12-10-16(15)13-19/h5-8,13-14,18H,2-4,9-12H2,1H3,(H,22,25)
InChI key:InChIKey=WROHEWWOCPRMIA-UHFFFAOYSA-N
SMILES:O=C(NC)C1=CN=C(OC2=CC=C3C(=C2)CCN(CC3)C4CCC4)C=C1
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
GSK189254A REF: TM-TQ0066CAS: 720690-73-3 | 98.71% | 52.00 €~495.00 € | Thu 16 May 24 | |
GSK189254A REF: 3D-VDB69073CAS: 720690-73-3 | Min. 95% | To inquire | Thu 20 Jun 24 |
GSK189254A
CAS:720690-73-3
GSK189254A (GSK189254) is a potent and specific histamine H3 receptor antagonist (pKi values: 9.59-9.90 and …
Formula:
C21H25N3O2
Purity:
98.71%
Color and Shape:
Solid
Molecular weight:
351.44
Ref: TM-TQ0066
1mg | 52.00 € | |
5mg | 92.00 € | |
10mg | 122.00 € | |
50mg | 343.00 € | |
100mg | 495.00 € |
Estimated delivery in United States, on Thursday 16 May 2024
GSK189254A
CAS:720690-73-3
GSK189254A is a drug that is a novel, potent, and selective H3 receptor antagonist. GSK189254A …
Formula:
C21H25N3O2
Purity:
Min. 95%
Molecular weight:
351.44 g/mol
Ref: 3D-VDB69073
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024